Heidelberg Innovation PresseHeidelberg Innovation - einer der führenden deutschen Venture-Capital-Gesellschaften im Bereich der Life Sciences
http://www.hd-innovation.de/en/presse/
Biofrontera AG lists New Shares at the regulated stock market
http://www.hd-innovation.de/en/presse/?id=677
2012-05-02Cellzome publishes in Nature Chemical Biology the discovery of a selective Pl3Kg inhibitor driven by the Kinobeads platform
http://www.hd-innovation.de/en/presse/?id=678
2012-04-29Santhera Shareholders Approve all Board Proposals at Annual Shareholders' Meeting
http://www.hd-innovation.de/en/presse/?id=682
2012-04-23Santheera Joins EU-funded EndoStem Consortium in Preparation for Clinical Study with Omigapil in Congenital Muscular Dystrophies
http://www.hd-innovation.de/en/presse/?id=679
2012-04-11Biofrontera and Bipharma sign exclusive marketing and distribution agreement for Ameluz for the Benelux
http://www.hd-innovation.de/en/presse/?id=676
2012-04-04Biofrontera publishes financial report 2011
http://www.hd-innovation.de/en/presse/?id=672
2012-03-30Biofrontera and Allergan sign marketing and distribution agreement for Ameluz in Spain
http://www.hd-innovation.de/en/presse/?id=669
2012-03-29Biofrontera AG: 4,402,682 shares subscribed in capital increase
http://www.hd-innovation.de/en/presse/?id=668
2012-03-23Digilab to Market FAST Protein Array Products
http://www.hd-innovation.de/en/presse/?id=673
2012-03-14Biofrontera AG decides on capital increase
http://www.hd-innovation.de/en/presse/?id=665
2012-03-02